Gee Sarah F, Joly Sophie, Soll David R, Meis Jacques F G M, Verweij Paul E, Polacheck Itzhack, Sullivan Derek J, Coleman David C
Microbiology Research Unit, Department of Oral Medicine and Oral Pathology, School of Dental Science and Dublin Dental Hospital, Trinity College, University of Dublin, Dublin 2, Republic of Ireland.
J Clin Microbiol. 2002 Feb;40(2):556-74. doi: 10.1128/JCM.40.2.556-574.2002.
The present study investigates further the population structure of Candida dubliniensis and its ability to exhibit microevolution. Using 98 isolates (including 80 oral isolates) from 94 patients in 15 countries, we confirmed the existence of two distinct populations within the species C. dubliniensis, designated Cd25 group I and Cd25 group II, respectively, on the basis of DNA fingerprints generated with the C. dubliniensis-specific probe Cd25. The majority of Cd25 group I isolates (48 of 71, 67.6%) were from human immunodeficiency virus (HIV)-infected individuals, whereas the majority of Cd25 group II isolates (19 of 27, 70.4%) were from HIV-negative individuals (P < or = 0.001). Nucleotide sequence analysis of the internal transcribed spacer (ITS) regions of the rRNA genes from 19 representative isolates revealed the presence of four separate genotypes. All of the Cd25 group I isolates tested belonged to genotype 1, while the Cd25 group II population was comprised of three distinct genotypes (genotypes 2 to 4), which corresponded to distinct clades within the Cd25 group II population. These findings were confirmed using genotype-specific PCR primers with 70 isolates. We also showed that C. dubliniensis can exhibit microevolution in vivo and in vitro as occurs in other yeast species. DNA fingerprinting using the C. dubliniensis probes Cd25, Cd24, and Cd1 and karyotype analysis of multiple oral isolates recovered from the same specimen from each of eight separate patients revealed microevolution in six of eight of the clonal populations. Similarly, sequential clonal isolates from various anatomical sites in two separate patients exhibited microevolution. Microevolution was also shown to occur when two clinical isolates susceptible to fluconazole were exposed to the drug in vitro. The epidemiological significance of the four C. dubliniensis genotypes and the ability of C. dubliniensis to undergo microevolution has yet to be established.
本研究进一步探究了都柏林念珠菌的种群结构及其发生微进化的能力。我们使用来自15个国家94名患者的98株分离株(包括80株口腔分离株),基于用都柏林念珠菌特异性探针Cd25生成的DNA指纹图谱,证实了都柏林念珠菌物种内存在两个不同的种群,分别命名为Cd25 I组和Cd25 II组。Cd25 I组的大多数分离株(71株中的48株,67.6%)来自感染人类免疫缺陷病毒(HIV)的个体,而Cd25 II组的大多数分离株(27株中的19株,70.4%)来自HIV阴性个体(P≤0.001)。对19株代表性分离株的rRNA基因内部转录间隔区(ITS)进行核苷酸序列分析,发现存在四种不同的基因型。所有测试的Cd25 I组分离株均属于基因型1,而Cd25 II组种群由三种不同的基因型(基因型2至4)组成,它们对应于Cd25 II组种群内不同的进化枝。使用基因型特异性PCR引物对70株分离株进行检测,证实了这些发现。我们还表明,都柏林念珠菌可在体内和体外发生微进化,就像其他酵母物种一样。使用都柏林念珠菌探针Cd25、Cd24和Cd1进行DNA指纹图谱分析,以及对从8名不同患者的同一标本中回收的多个口腔分离株进行核型分析,结果显示在8个克隆种群中的6个中发生了微进化。同样,来自两名不同患者不同解剖部位的连续克隆分离株也表现出微进化。当两株对氟康唑敏感的临床分离株在体外接触该药物时,也显示出微进化。都柏林念珠菌四种基因型的流行病学意义以及都柏林念珠菌发生微进化的能力尚未确定。